COMMUNIQUÉS West-GlobeNewswire

PhaseBio Announces Completion of Phase 2a Clinical Trial of PB2452 for the Reversal of the Antiplatelet Activity of Ticagrelor
24/09/2019
Preliminary Results from Supratherapeutic-Dose Ticagrelor Cohort Are Consistent with Earlier Phase 2a Cohorts and Previously Published Phase 1 Trial MALVERN, Pa. and SAN DIEGO, Sept. 24, 2019 (GLOBE NEWSWIRE) -- [...]
Galapagos initiates Phase 1 trial for second Toledo compound
24/09/2019
Second generation compound of novel target class with dual action in inflammatory disorders Discovered and validated on Galapagos’ target discovery platform Mechelen, Belgium; 24 September 2019, 22.01 CET – Galapagos NV [...]
Aeterna Zentaris Announces Closing of Approximately $5.0 Million Registered Direct Offering
24/09/2019
CHARLESTON, S.C., Sept. 24, 2019 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS), a specialty biopharmaceutical company engaged in commercializing novel pharmaceutical therapies, principally through [...]
Micron Solutions, Inc. Announces $1M Annual Contract Award from an innovation leader in the Defense Market
24/09/2019
FITCHBURG, Mass., Sept. 24, 2019 (GLOBE NEWSWIRE) -- Micron Solutions, Inc. (NYSE American: MICR) (the “Company”), a diversified contract manufacturing organization, through its wholly-owned subsidiary, Micron Products [...]
Gratian Schindler joins Biotii Technologies as Advisor
24/09/2019
VANCOUVER, British Columbia, Sept. 24, 2019 (GLOBE NEWSWIRE) -- Biotii Technologies Corp. (the “Company” or " Biotii " ) is pleased to announce that the Company has entered into an advisory agreement (the “Agreement”) [...]
Bavarian Nordic Announces U.S. FDA Approval of JYNNEOS™ (Smallpox and Monkeypox Vaccine, Live, Non-replicating) for Prevention of Smallpox and Monkeypox Disease in Adults
24/09/2019
First FDA approved non-replicating smallpox vaccine Only FDA approved vaccine for prevention of monkeypox Company granted Priority Review Voucher Conference call and webcast tomorrow at 3:00 PM CEST COPENHAGEN, Denmark [...]
Allied Corp., a Medical Cannabis Company, Approved to Uplist to OTCQB Venture Market
24/09/2019
KELOWNA, British Columbia, Sept. 24, 2019 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied") (OTCQB: ALID), an international medical cannabis company focused on creating and providing targeted cannabinoid health solutions, is [...]
DLT Resolution Launches DLT Telecom in Canada and the United States
24/09/2019
Toronto, ON, Sept. 24, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- DLT Resolution Inc. (OTC: DLTI), a Distributed Ledger Technology (“Blockchain”) Data Management, Information Technology and Telecommunications company [...]
Judge Orders Agency to Let Nonresidents Into NM Medical Cannabis Program
24/09/2019
Ultra Health triggers nationwide cannabis reform with ruling to allow three-year cards for nonresidents SANTA FE, N.M., Sept. 24, 2019 (GLOBE NEWSWIRE) -- Santa Fe District Court Judge Bryan Biedscheid affirmed a [...]
LIDDS: Wikow Invest is still the biggest shareholder in LIDDS (publ)
24/09/2019
UPPSALA, SWEDEN. LIDDS AB (publ) – Due to a technical error by a market data provider, Wikow Invest was removed as largest shareholder in Top 10 tables at several trading and information sites over the past few days. [...]
GW Pharmaceuticals to Present at the 2019 Cantor Global Healthcare Conference on Wednesday, October 2nd, 2019
24/09/2019
CARLSBAD, Calif., Sept. 24, 2019 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc and its U.S. subsidiary Greenwich Biosciences Inc. (NASDAQ: GWPH, GW, the Company or the Group), the world leader in the development and [...]
Axiom Real-Time Metrics Exhibiting at Outsourcing in Clinical Trials in Southern California
24/09/2019
TORONTO, Sept. 24, 2019 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics (“Axiom”), premier provider of unified eClinical solutions and services is exhibiting at the 7 th Annual Outsourcing in Clinical Trials (“OCT”) SoCal [...]
CEO of INmune Bio Inc. Discusses Company Accomplishments at Nasdaq’s MarketSite and Announces Presentation at World Immunotherapy Congress
24/09/2019
La Jolla, CA., Sept. 24, 2019 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB ), an immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, today [...]
Q-Centrix Achieves Top Cybersecurity Certification, Advances Standards in Healthcare Information Technology
24/09/2019
SOC 2 compliance independently verifies Q-Centrix’s adherence to best practices for data security. Chicago, Sept. 24, 2019 (GLOBE NEWSWIRE) -- Q-Centrix®, a leading quality data solutions provider for hospitals and [...]
Exactus, Inc. Hemp Farm on Track to Produce Approximately 30,000 Pounds of Top Flower
24/09/2019
DELRAY BEACH, Fla., Sept. 24, 2019 (GLOBE NEWSWIRE) -- Exactus, Inc. (OTCQB:EXDI) (the “Company”), a farmer and manufacturer of hemp-derived phytocannabinoid products, today announced that its executive team has [...]
Todos Medical and Orot+ Announce First Patient Enrolled in Pre-Commercial Launch Preparations of TM-B1 and TM-B2 Breast Cancer Blood Screening Tests in Europe
24/09/2019
REHOVOT, Israel, Sept. 24, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF) , a clinical-stage in-vitro diagnostics company focused on the development of blood tests for the early detection of cancer and [...]
Cerner and GetWellNetwork Bring More Convenience and Accessibility to Health Care
24/09/2019
Cerner to Improve Functionality for Clients and Patients Through Third-party Solutions KANSAS CITY, Mo., Sept. 24, 2019 (GLOBE NEWSWIRE) -- Cerner Corporation (NASDAQ: CERN), a global health platform and innovation [...]
Achieve TMS East Celebrates the Opening of a New Office in West Hartford, Connecticut
24/09/2019
WEST HARTFORD, Conn., Sept. 24, 2019 (GLOBE NEWSWIRE) -- Achieve TMS East , New England’s largest provider of Deep Transcranial Magnetic Stimulation (Deep TMS) therapy for the treatment of major depressive disorder ( [...]
Catalent and Minerva Neurosciences Enter Commercial Supply Agreement for Schizophrenia Drug Roluperidone
24/09/2019
WALTHAM, Mass. and SOMERSET, N.Y., Sept. 24, 2019 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of innovative therapies to treat [...]

Pages